Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

Deal volumes for pharmaceutical deals were lower in 2023 than they were 10 years ago and have been lower, on average, than ...

Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...

The underlying issue for pharma companies using AI lies in the quality of the inputs and how AI models are used.

Blackweek’s inaugural three-day conference featured several health-focused panels discussing health equity and more inclusive ...

The blue blood of threatened horseshoe crabs contains a chemical essential for testing the safety of vaccines. So these ...

Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...

Scilex Pharma may soon flee the nest after its parent company Scilex Holding’s board of directors granted permission to ...

The evolution of Pharma 4.0 integrates advanced technologies, transforming drug development and manufacturing with improved ...

Purvi Tailor, Ferring Pharmaceuticals' VP of HR, says focusing holistically on worker well-being is crucial for retaining top ...

Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion. Read more on ...

Enhanced Compliance: CMDM ensures that all HCP and HCO data is accurate and up-to-date, which is critical for meeting ...